In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines
M Schmidt-Hieber, R Dabrowski, A Weimann… - Investigational new …, 2012 - Springer
The novel AKT inhibitor perifosine, a synthetic alkylphospholipid, is currently being
investigated in clinical trials for the treatment of different hematological and oncological …
investigated in clinical trials for the treatment of different hematological and oncological …
[引用][C] In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines
M Schmidt-Hieber, R Dabrowski, A Weimann… - Investigational New …, 2010 - cir.nii.ac.jp
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and
lenalidomide against different cell lines | CiNii Research CiNii 国立情報学研究所 学術情報 …
lenalidomide against different cell lines | CiNii Research CiNii 国立情報学研究所 学術情報 …
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines
M Schmidt-Hieber, R Dabrowski, A Weimann… - Investigational New …, 2012 - infona.pl
The novel AKT inhibitor perifosine, a synthetic alkylphospholipid, is currently being
investigated in clinical trials for the treatment of different hematological and oncological …
investigated in clinical trials for the treatment of different hematological and oncological …
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines.
M Schmidt-Hieber, R Dabrowski… - Investigational new …, 2010 - europepmc.org
The novel AKT inhibitor perifosine, a synthetic alkylphospholipid, is currently being
investigated in clinical trials for the treatment of different hematological and oncological …
investigated in clinical trials for the treatment of different hematological and oncological …
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines
M Schmidt-Hieber, R Dabrowski… - Investigational …, 2012 - pubmed.ncbi.nlm.nih.gov
The novel AKT inhibitor perifosine, a synthetic alkylphospholipid, is currently being
investigated in clinical trials for the treatment of different hematological and oncological …
investigated in clinical trials for the treatment of different hematological and oncological …
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines
M Schmidt-hieber, R Dabrowski… - Investigational New …, 2012 - search.proquest.com
The novel AKT inhibitor perifosine, a synthetic alkylphospholipid, is currently being
investigated in clinical trials for the treatment of different hematological and oncological …
investigated in clinical trials for the treatment of different hematological and oncological …